GlassScriptPhysician profile
Brittany Estok
NPI 1588071955
$10,347.99
in general payments reported to CMS, 2019-2025
37 companies · $2,556 in 2025
The $2,556 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $319 · 2022: $2,283 · 2023: $1,926 · 2024: $3,265 · 2025: $2,556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,496 · Education: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,496.14 |
| Education | $249.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,953.68 | 2021-2025 | |
| Janssen Biotech, INC. | $1,199.26 | 2022-2025 | Tremfya, Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $1,189.03 | 2022-2025 | Entyvio, Gattex, Eohilia |
| Ardelyx, INC. | $846.21 | 2022-2025 | Ibsrela |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $764.74 | 2022-2025 | Xifaxan, Trulance |
| Madrigal Pharmaceuticals | $588.04 | 2024-2025 | Rezdiffra, Resmetirom |
| Lilly USA, LLC | $474.77 | 2023-2025 | Omvoh |
| Janssen Scientific Affairs, LLC | $332.80 | 2022-2023 | Stelara |
| Gilead Sciences, INC. | $325.29 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $315.50 | 2022-2024 | Dupixent |
| Aimmune Therapeutics, INC. | $313.63 | 2023-2025 | Zenpep |
| Phathom Pharmaceuticals, INC. | $286.39 | 2024-2025 | Voquezna |
| Teva Pharmaceuticals USA, INC. | $144.05 | 2021 | |
| Incyte Corporation | $129.37 | 2021 | |
| Intercept Pharmaceuticals, INC. | $117.98 | 2023-2025 | Ocaliva |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $117.18 | 2022 | |
| Neurocrine Biosciences, INC. | $116.63 | 2022 | |
| Nestle Healthcare Nutrition INC. | $115.11 | 2022-2023 | |
| Vivus LLC | $109.17 | 2022-2025 | Pancreaze |
| Biogen, INC. | $99.84 | 2022 | |
| Redhill Biopharma INC. | $90.24 | 2022-2023 | Talicia, Movantik, Aemcolo |
| Olympus America INC. | $86.84 | 2022 | |
| Novo Nordisk INC | $84.76 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Braintree Laboratories, INC. | $76.11 | 2023-2025 | Suflave |
| Genzyme Corporation | $72.54 | 2022-2023 | |
| Celgene Corporation | $69.69 | 2022-2023 | Zeposia |
| Qol Medical, LLC | $69.22 | 2022 | |
| Biocon Biologics INC | $47.59 | 2025 | Yesintek |
| Pfizer INC. | $45.60 | 2025 | |
| Merck Sharp & Dohme LLC | $36.47 | 2024 | Dificid |
| Mallinckrodt Hospital Products INC. | $21.52 | 2023 | Terlivaz |
| Cepheid | $21.23 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.99 | 2023 | |
| Exact Sciences Corporation | $19.32 | 2024 | Cologuard Collection Kit |
| Ironwood Pharmaceuticals, INC | $19.04 | 2022 | |
| Evoke Pharma, INC. | $18.00 | 2023 | Gimoti |
| Organon LLC | $11.16 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Estok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.